Although BCG mycobacteria are relatively weak inducers of bioactive IL-12p70 in human dendritic cells in the absence of additional costimulation like CD154 or IFN-γ (figure 3b), IL-12 has been shown to be essential for therapeutic efficacy in experimental BCG immunotherapy of bladder cancer [24]. This evidence concerns the gene IFNG and urinary bladder carcinoma.